- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
![Cas No. 1269440-58-5, 2-Chloro-4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/joBpqKkrllSRikiijlllin/1269440.gif) |
![Cas No. 1269440-58-5, 2-Chloro-4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/joBpqKkrllSRikiijlllin/1269440-100-100.gif)
1269440-58-5
C10H10ClIN4
348.57
1.86±0.1
Anticancer
Encorafenib
8/5/2033 (Encorafenib)
BRAF
![Cas No. 1269440-58-5, 2-Chloro-4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/joBpqKkrllSRikiijlllin/1269440-800-800.gif)
DESCRIPTION
Encorafenib, a potent BRAF inhibitor, has demonstrated remarkable efficacy in treating patients with advanced melanoma harboring BRAF mutations. Our meticulously crafted intermediates ensure a seamless manufacturing process, enabling the timely production and supply of this life-saving medication. Join forces with us to revolutionize cancer care, providing patients with renewed hope and improved outcomes. Together, let's pave the way for a brighter future with Encorafenib.
